Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07317245

HUmanitas PROtontherapy (HU-PRO)

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Proton therapy is a cancer treatment, similar to the more commonly used radiation therapy. It uses radiation to destroy cancer cells and helps control the disease in the treated area. However, when proton therapy is compared with standard radiation therapy, many studies show fewer side effects and better disease control. This is due to the unique physical properties of the particles used in proton therapy. At present, in Italy, this innovative treatment is available only for selected diseases, as defined by national guidelines. For this reason, it is very important to collect as much data as possible to support the further development of proton therapy and to improve treatment safety and effectiveness.

Conditions

Timeline

Start date
2026-01-12
Primary completion
2036-01-01
Completion
2036-01-01
First posted
2026-01-05
Last updated
2026-01-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07317245. Inclusion in this directory is not an endorsement.